• Skip to primary navigation
  • Skip to main content

National Forum

  • Home
  • About
    • Advisory Leadership Council
    • Board of Directors
    • History
    • National Forum Awards
    • Team
    • Support
  • Collaborations
    • Counter Cholesterol™
    • Million Hearts®
    • Move with the Mayor™
    • Signature Reports
    • Stronger Hearts™
    • Value & Access
      • Value & Innovation Forum
    • World Heart Day
  • Events
    • Heart Failure Roundtable
    • 2020 Annual Meeting
    • Value & Innovation Forum
    • Meeting Archives
      • 2020 Mid-Year Meeting
      • 2019 Annual Meeting
      • 2019 Virtual Convening on Stroke
      • 2019 Mid-Year Member Meeting
      • 2018 Annual Meeting
      • 2018 Mid Year Meeting
  • Members
    • Membership
  • Newsroom
  • Search Toggle
  • Skip to content

National Forum Statement on Amgen’s Repatha Price Change

Posted on 10.26.18

The National Forum issued the following statement in response to Amgen’s announcement that it cut the price of its cholesterol-lowering drug, Repatha, by 60 percent.

Leaders representing patients, providers, public health, payers and pharma/biotech have joined forces through the National Forum Value & Access Initiative to enhance health and well-being by supporting people’s access to evidence-based care that is appropriate for them.

The price change announced by Amgen appears to support the Value & Access Initiative’s consensus strategy, to align incentives for all stakeholders

  • It appears designed to reduce consumers’ out-of-pocket costs.
  • It may mean that health plans and pharmacy benefit managers can better provide evidence-based drug therapy for patients who may benefit most.
  • Amgen’s assumption that increased sales will offset reduced margins may mean this new pricing strategy will preserve incentives for future innovation

The National Forum and its members will watch eagerly, hoping to see improved access to this cholesterol-lowering therapy for the people who may benefit most.

Categories: In the News, Value & Access

1150 Connecticut Ave., NW, Suite 300, Washington, DC 20036 Phone: (866) 894-3500
Copyright © 2021 National Forum for Heart Disease & Stroke Prevention. All Rights Reserved
  • Facebook
  • Twitter